• European Workshops on Cell Death (EWCD), Speaker, ‘Dissecting the Link between Bioenergetic Status and Autophagy as a Mechanism of Tumour Cell Resistance to BH3 Mimetics’, 6 - 11 May 2018, Italy
  • British Toxicology Society (BTS) Annual Congress, Speaker, ‘Understanding the Galactose-conditioning Model in HepG2 cells: Beyond bioenergetics reveals additional mechanisms of mitochondrial toxicity’ , 2018, UK (highly commended for talk)
  • MitOx, Poster, ‘Understanding the Galactose-conditioning Model in HepG2 cells’, 2017, Oxford
  • British Toxicology Society (BTS) Annual Congress, Speaker, 'Understanding the Galactose-conditioning Model in HepG2 cells: Beyond bioenergetics’, 2017, Liverpool
  • In Vitro Toxicology Society Annual Congress, Speaker, 'The galactose-conditioning model in HepG2 cells: an In Vitro tool for examining mitochondrial toxicology', 2016, Glasgow
  • British Toxicology Society (BTS) Annual Congress, Poster, 'Galactose-conditioning of HepG2 cells causes significant changes to protein expression, cell signalling and response to cytotoxic stimuli', 2016, Manchester
  • In Vitro Toxicology Society Poster award, presented for my poster entitled 'Galactose-conditioning of HepG2 cells causes significant changes to protein expression, cell signalling and response to cytotoxic stimuli', given by British Toxicology Society (BTS) at their 2016 annual congress.

Trim content

® The Pirbright Institute 2020 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.